What is Impact Investing?
About Impact Investing
Impact investing is the practice of making purposeful investments that help achieve social benefits – while generating financial returns. In the charitable space, impact investing has been embraced by several prominent foundations as a way to ensure that assets committed to advancing social good through grantmaking, are invested in projects that align with those values.
Unlike charitable giving, impact investing provides individuals an opportunity to achieve both social and financial returns. Although impact investing is a relatively new strategy, the global market size is estimated to be $228 billion and growing, and impact investments have had a successful track record. A 2018 survey conducted by the Global Impact Investing Network found that the vast majority of impact investments met expectations for both impact and financial returns. Now, there is a real opportunity to apply what has worked so well in other sectors to health care, including medical research and drug development.
Precision Medicine is Ideal for Impact Investing
By better predicting how cells will react to medicines, doctors can eliminate the trial and error phase of an individual’s treatment journey, leading to faster cures. Precision medicine could save millions of lives each year by making it possible to tailor treatments based on patients’ unique genetics, lifestyle and environmental factors.
But this work can’t be done without investment. We need to close the gap between innovative health care organizations that need investors and healthcare-minded individuals looking to make their money work for them by developing cures to extend and save lives. MCC enables impact investors to help close the gap and put an end to pancreatitis.
